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Biofilm formation in wounds is considered a major barrier to successful treatment, and
has been associated with the transition of wounds to a chronic non-healing state. Here,
we present a novel laboratory model of wound biofilm formation using ex-vivo porcine
skin and a custom burn wound array device. The model supports high-throughput
studies of biofilm formation and is compatible with a range of established methods for
monitoring bacterial growth, biofilm formation, and gene expression. We demonstrate
the use of this model by evaluating the potential for bacteriophage to control biofilm
formation by Staphylococcus aureus, and for population density dependant expression
of S. aureus virulence factors (regulated by the Accessory Gene Regulator, agr) to signal
clinically relevant wound infection. Enumeration of colony forming units and metabolic
activity using the XTT assay, confirmed growth of bacteria in wounds and showed
a significant reduction in viable cells after phage treatment. Confocal laser scanning
microscopy confirmed the growth of biofilms in wounds, and showed phage treatment
could significantly reduce the formation of these communities. Evaluation of agr activity
by qRT-PCR showed an increase in activity during growth in wound models for most
strains. Activation of a prototype infection-responsive dressing designed to provide a
visual signal of wound infection, was related to increased agr activity. In all assays,
excellent reproducibility was observed between replicates using this model.
Keywords: ex-vivo burn wound model, infection, Staphylococcus aureus, bacteriophage therapy, biofilm,
accessory gene regulator, infection responsive materials
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INTRODUCTION
It has been estimated that 175,000 children and adults visit
A&E departments for treatment related to burn injuries each
year in the UK (National Burn Care Review Committee Report,
2001). Most wounds heal fully with minimal intervention,
but 10–20% of those will become infected posing a serious
risk to patient health (Wibbenmeyer et al., 2006). Infection
delays healing and promotes scarring, increases the use of
antibiotics, and greatly increases the cost of treatment (Bowler
et al., 2001; Mayhall, 2003; Church et al., 2006; Wounds UK
Best Practice Statement, 2013). Colonization of the wound by
bacteria begins almost immediately after injury, and usually
includes opportunistic pathogenic bacteria from the surrounding
environment or the patient’s own microbiome (Bowler et al.,
2001; Mayhall, 2003; Church et al., 2006; Rafla and Tredget,
2011; Lebeaux et al., 2013). In many cases only a low-level
population of microbes will develop and persist in the wound,
which poses no significant barrier to healing. However, in
some cases the microbial population will expand to levels
that overwhelm immune clearance, impede the normal healing
process, and lead to invasive infection that requires treatment
(Church et al., 2006; Wounds UK Best Practice Statement,
2013).
This clinically relevant infection also often involves the
formation of biofilms in the wound bed which present particular
challenges to wound management and successful treatment.
Biofilms are dense bacterial communities embedded in a matrix
of exopolymeric substances which exhibit distinct physiology,
phenotypes, and altered gene expression compared to planktonic
cells (Donlan and Costerton, 2002; Zhao et al., 2013; Ganesh
et al., 2015; Percival et al., 2015). These features of biofilms make
them resilient to environmental factors and immune clearance,
and also considerably reduces susceptibility to antibiotics and
other topical antimicrobial agents (Donlan and Costerton, 2002;
Zhao et al., 2013; Ganesh et al., 2015; Percival et al., 2015).
Antibiotics typically perform poorly against bacterial biofilms
even when constituent cells are fully susceptible to clinically
relevant concentrations in a planktonic state. Congruent with
these properties of biofilms is the association between biofilm
formation in the wound and treatment failure, poor clinical
outcomes, and development of chronic non-healing wounds
(Zhao et al., 2013; Ganesh et al., 2015; Percival et al., 2015).
The study of biofilm formation in burn wounds and the
evaluation of methods to control these infections is often limited
by access to relevant and appropriate models. In particular, early
stage laboratory studies aimed at screening and developing new
antimicrobial or anti-biofilm agents, or providing fundamental
molecular genetic insights into bacterial biofilm formation in
wounds, are often hampered by a lack of models which afford
both reasonable throughput yet provide a good representation of
biofilm formation in burn wounds. Ideally, such models should
also be low-cost and simple to operate, support high throughput
screening, offer good reproducibility, and be compatible with
a wide range of established techniques for measuring or
visualizing various aspects of microbial physiology, growth,
biofilm formation, and gene expression.
Although a number of excellent in-vivo models of wound
infection have been described and have considerably enhanced
understanding of wound biofilm formation, their use is subject
to ethical and economic considerations, and relatively few are
focused on burn wounds specifically (Dai et al., 2011; Lebeaux
et al., 2013; Roy et al., 2014; Ganesh et al., 2015; Seaton
et al., 2015). Porcine models are considered to provide the best
representation of human skin and wound healing as well as
human burn wound infection (Dai et al., 2011; Ganesh et al.,
2015; Seaton et al., 2015). However, the use of large animals
in research and the impact of burn wound injuries on animal
welfare amplify regulatory issues and the costs of studies using
these models, restricting access and the types of study in which
their use is feasible and justified (Dai et al., 2011; Seaton et al.,
2015). Murine models are often more affordable but have similar
ethical issues, and are considered to be less representative of
human wound infection. The small size of these animals also
limits the number of wounds that can be made and statistical
robustness that can be achieved (Dai et al., 2011; Ganesh et al.,
2015; Seaton et al., 2015).
Conversely, while many in-vitromodels are simple, affordable,
and scalable for screening type applications, and allow study
of the main features of biofilms, these often provide a poor
representation of the wound environment and are largely
restricted to growth of biofilms on abiotic surfaces (Lebeaux et al.,
2013; Ganesh et al., 2015). Mammalian cell culture based models
which seek to provide biotic surfaces for biofilm formation in the
form of cell monolayers are also available, but do not provide
good representation of skin structure, are often more costly and
difficult to operate, and less well-suited to support large scale
screening studies (Lebeaux et al., 2013; Ganesh et al., 2015).
As such, there remains scope to develop additional in-vitro
or ex-vivo models that can support investigation of burn wound
infection and biofilm formation at early stages, particularly for
studies with a requirement to screen numerous compounds,
bacterial isolates, or understand fundamental aspects of biofilm
formation. Previously we have described the use of ex-vivo
porcine skin sections with thermal damage comparable to partial
thickness burns, for the study of bacterial biofilm formation
and novel infection responsive dressing materials (Thet et al.,
2015). This model provides many of the desirable features
noted above, and here we extend this work to develop a high-
throughput and reproducible ex-vivo porcine skin model of
wound infection and biofilm formation. We demonstrate the
use of this model by evaluating the potential for bacteriophage
therapy to control biofilm formation in this setting, and the
potential to exploit population density dependent changes in
virulence gene expression for early detection of clinically relevant
infection.
MATERIALS AND METHODS
Bacteria and Growth Conditions
Bacteria were cultured in Tryptone Soy Broth (TSB) at 37◦C with
shaking, or on TSB solidified by addition of 15 g/L Technical
agar (TSA). Soft agar overlays, used for phage enrichments,
purification, and enumeration, were derived from TSB and
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contained 6.5 g/L Technical agar (S-TSA). All chemicals, reagents
and growth media were obtained from Fisher Scientific (UK),
or Sigma (UK) unless otherwise stated. Staphylococcus aureus
strains used in this study are described in Table 1, and represent
a range of hospital or community acquired methicillin-resistant
S. aureus (MRSA), epidemic MRSA (EMRSA), and methicillin-
sensitive S. aureus (MSSA) from active infection. Spontaneous
rifampicin-resistant mutants of MRSA252 were generated by
serial passage on TSB agar supplemented with increasing
concentrations of rifampicin from 5 to 100µg/mL. All work
involving bacterial pathogens was conducted in containment
level 2 laboratories and in compliance with institutional
guidelines and UK legislation on Containment of Substances
Hazardous to Health.
Phage Isolation and Purification
Phage DRA88 has previously been isolated by the authors
(Alves et al., 2014). Phage SAB4328-A was isolated from sewage
collected from wastewater treatment plants in the UK (Hailsham
NorthWWTP, East Sussex), by performing bacterial enrichments
with a recent S. aureus clinical isolate (from Royal Sussex County
Hospital, UK). Hundred milliliters of wastewater was mixed with
387.5mL of LB, and inoculated with 2.5mL of an overnight
culture of S. aureus B4328. This was incubated at 37◦C overnight
without shaking. Ten milliliters of aliquots were centrifuged
(3,000 × g for 30min), and supernatants filtered into fresh
sterile tubes using 0.45µm pore syringe filters (Sartorius, UK).
Hundred microliters of supernatant (containing enriched phage)
were mixed with 100 µL of host culture and incubated for 5min
at room temperature, then mixed with 3mL S-TSA. The S-TSA
mixture was poured over TSA plates to create overlays, and
incubated at 37◦C overnight once set. Single well-isolated plaques
with different morphologies were picked off and resuspended in
300 µL SM Buffer (100mM NaCl, 10mMMgSO4.7H2O, 50mM
Tris-HCl pH 7.5, 0.01% gelatine), the phage suspension serially
diluted, and plated on S-TSA plates containing host bacteria
as described above. The process was repeated until bacterial
lawns showed homogeneity of plaque morphology. Finally, an
individual plaque was picked off and resuspended in SM buffer
for use in subsequent experiments.
Preparation of High Phage Stocks
For the preparation of high titer stocks, phage SAB4328-A
was propagated on S. aureus B4328, and phage DRA88 was
propagated on S. aureus 15981. Briefly, 100 µL of phage
suspension and 100 µL of host culture were mixed and left for
5min at room temperature. The bacterial and phage mixture was
then added to 3mL of S-TSA, mixed gently, and poured over
TSA plates. After overnight incubation at 37◦C, plates displaying
confluent lysis were selected and 3mL of SMbuffer supplemented
with 2% (v/v) chloroform were added before incubation at 37◦C
for 4 h. High-titer phage solution was removed from the plates,
centrifuged (8,000 × g for 10min) to remove cell debris, and
then filter-sterilized (pore size, 0.22µm). In order to concentrate
the phage lysate 20% PEG-8000 solution supplemented with 1M
NaCl to a final concentration of 10% was added to the lysate
and incubate at 4◦C overnight. The mixture was centrifuged at
TABLE 1 | Bacterial strains and bacteriophage used in this study.
S. aureus
Strain/Phage
Description Reference/Source
RN6390B NTCT8325 cured of three
prophages. Agr+ wild type strain
capable of lysing lipid vesicles
Peng et al., 1988;
Laabei et al., 2014
RN6911 Isogenic agr knockout mutant of
RN6390B, incapable of lysing
lipid vesicles
Sakoulas et al., 2009;
Laabei et al., 2014
B4328 Clinical wound isolate. Use to
isolate and propagate phage
SAB4328-30
This study—Royal
Sussex County
Hospital
MSSA 3
MSSA 10
MSSA 16
MSSA 21
MSSA 49
MSSA 52
MSSA 56
MSSA 67
MSSA 69
MSSA 71
MSSA 114
MSSA 160
MRSA 82
MSSA 476
MSSA 707
MSSA 15981
MRSA 252
MRSA 378
MRSA 455
EMRSA 1
EMRSA 9
EMRSA 13
EMRSA 15
EMRSA 16
Strains from patients with
invasive S. aureus infection
collected between 1997 and
1998 in Oxford UK (both hospital
and community acquired
isolates)
Enright et al., 2000
USA300 Community acquired epidemic
clone of methicillin resistant S.
aureus
McDougal et al., 2003
15981 Clinical S aureus isolate used to
propagate phage DRA88
Alves et al., 2014
MRSA252-
RifR
Derivative of MRSA252 rendered
resistant to rifampicin through
serial sub-culture
This study
Phage
DRA88
S. aureus phage capable of
infecting a broad range of clinical
isolates
Alves et al., 2014
Phage
SAB4328-A
Isolated against S. aureus B4328 This study
8,000× g for 20min, the pellet resuspended in SM buffer and 1/5
volume chloroform added, followed by a slow centrifugation to
collect the aqueous phase with phage. The suspension was then
stored at 4◦C for further use.
Electron Microscopy
Purified phage particles at a concentration of 109 PFU/mL
were deposited on 300 mesh carbon-coated copper grids (Agar
Scientific, UK) and negatively stained with 1% uranyl acetate
(pH 4). The surface of the copper grids were ionized for
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FIGURE 1 | Burn Wound Array Device. The Burn Wound Array Device consists
of an array of 24 brass pins that rests in a temperature controlled heated
block. Pins are heated to the set temperature and the device signals the user
when this has been reached and tool is ready for use. (A) Heated block and
temperature controller with 24 pin array inserted and heating. (B) 24 pin array
resting on a section of porcine skin to generate thermal injuries.
2min immediately prior to sample deposition, 5 µL of phage
lysate were spotted on the surface of the grid and allowed
to stand for 1min, followed by 30 s negative staining and air
dried. Visualization was performed using a transmission electron
microscope JEOL JEM-1400Plus, operated at 120 kV (pixel size
= 0.1 nm), equipped with a Gatan OneView 4K CMOS digital
camera. For measurement estimations 10 images of each phage
were taken.
Ex-Vivo Burn Wound Model Set Up
Burn Wound Array Device (BWAD)
The device consists of 24 brass pins of 5mm diameter housed
in a single weighted block. This array is inserted in a heated
block, which elevates the temperature of each pin to the desired
temperature as specified by the user (Figure 1). The pin array
may then be used to generate a grid of 24 burn wounds derived
from exposure of skin to pins with identical temperature, time,
and pressure.
Burn Model Preparation
A schematic illustrating the basic set-up and operation of our
ex-vivo model is provided in Figure 2. Porcine skin used for
this study was supplied by Pirbright Institute (Surrey, UK) as
surplus/waste tissue from other experiments, or purchased from
Fresh Tissue Supplies Ltd. (Etchingham, UK). Tissues from
Pirbright were derived from Large White or Landrace cross
hybrid pigs (∼10 kg and of both sexes) from a commercial
farm. The use of porcine skin in this study was compliant with
relevant UK and EU legislation, and approved by the Pirbright
Animal Welfare and Ethical Review Board. Skin sections were
prepared by shaving, and rinsing under sterile deionized water.
The skin was sectioned into 10 cm2 segments and the surface
disinfected with a solution of 70% ethanol, and allowed to dry
in a laminar flow cabinet. The BWAD was pre-heated to 100◦C
and when at temperature the pin array was placed in contact
with the skin for 60 s to create a grid of burn wounds. To
avoid cross contamination of wounds during biofilm growth and
treatment evaluation, individual burn wounds with surrounding
undamaged tissue were excised from the skin section and
transferred to individual wells of 96 or 24 well plates as
required.
Evaluation of Bacterial Biofilm Formation and Impact
of Phage Therapy
To evaluate the growth of S. aureus biofilms in the ex-vivo
model we used S. aureus strain MRSA252 rendered resistant
to rifampicin (MRSA252-RifR), in order to facilitate specific
selection and enumeration of this strain at experimental end
points. Wounds prepared as described in model operation
(Figure 2) were excised using a sterile 6mm punch biopsy and
treated with 100µg/mL rifampicin to suppress commensal flora.
Excess liquid was removed and wounds inoculated with 5 µL of
S. aureus culture containing 104 CFU. Plates containing explants
were sealed in humidified bags and incubated at 37◦C for the
duration of experiments. To determine the potential for phage
to control S. aureus biofilm formation in this model, inoculated
wounds were treated with doses of phage at set intervals, and
bacterial growth and biofilm formation compared with untreated
controls at the end of experiments. Two distinct treatment
regimes were evaluated: (i) A single phage treatment 4 h after
inoculation of S. aureus in wounds, and evaluation of biofilms
at 24 h; (ii) 2 phage treatments at 4 h, and 24 h post inoculation
of S. aureus in wounds, and evaluation of biofilms at 48 h.
Phage treatments were introduced to wounds as 5 µL volumes
containing 106 pfu/mL at 4 h treatment, and 107 pfu/mL at
24 h treatment. Negative controls consisted of both infected and
uninfected wounds treated with PBS only.
Evaluation of agr Activity and Activation of
Infection-Responsive Dressings
Correlations between activation of prototype infection
responsive dressings (described by Thet et al., 2015) and
the activity of the population density controlled virulence
gene regulator agr, were determined for 28 strains of S. aureus
(Table 1). For this assay, the porcine skin was prepared as
described above, and wounds were generated as described above
but excised as 0.5 cm2 sections with a scalpel, transferred to
24 well plates, and inoculated with 108 CFU of S. aureus in a
20 µL volume, from fresh semi-log phase cultures at OD600
of 0.5. Wounds were subsequently overlayed with sections of
prototype dressing consisting of carboxyfluorescein loaded lipid
vesicles embedded in a hydrogel matrix (Thet et al., 2015). Plates
were sealed in humidified plastic bags and incubated for 6 h at
37◦C, 5% CO2. Dressing activation was evaluated subjectively
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FIGURE 2 | Ex-vivo burn wound model workflow. Graphical representation showing main stages of set-up and operation of the ex-vivo porcine burn wound model
used in this study. (I) Sections of porcine skin are initially prepared by shaving and surface disinfection in 70% ethanol solution; (II, III) The BWAD (see Figure 1) is
used to generate an array of consistent partial thickness burn injuries on porcine skin; (IV) If isolation of wounds is required, individual wounds may be excised using a
punch biopsy and transferred into wells of tissue culture plates. Wound arrays may be used directly on skin sections without excision. (V–VIII) Individual wounds are
inoculated with test organisms to simulate infection and wound biofilm formation. Potential treatments may be evaluated against a subset of infected wounds in the
array. (IX) Infected wounds are incubated under required conditions and biofilm formation, bacterial growth, and impact on interventions tested can be evaluated as
appropriate. Subsequent methods demonstrated in this study are: Recovery and enumeration of viable cells, quantification of metabolic activity via XXT reduction, the
selective staining of biofilms followed by direct imaging of biofilms through CLSM and measurement of fluorescence intensity, extraction of RNA, and quantification of
gene expression by qRT-PCR.
by eye based on dressing color change as either activated (“on”)
or as having no discernible color change (“off”). Figure 3
shows examples of activated (“on”) and non-activated (“off”)
dressings. Agr activity in corresponding wounds was evaluated
by quantitative reverse transcriptase real time PCR (qRT-PCR)
as described below.
Histology of Porcine Skin
To confirm that damage consistent with a burn injury was
generated by the BWAD, skin subjected to thermal injury was
prepared for tissue sectioning and compared with uninjured
skin from the same section. Excised wounds or regions of
uninjured skin were immersed in Optimal Cutting Temperature
compound, frozen in liquid nitrogen and 8µm thick sections
removed using a cryostat. Sections were placed onto Vectabond
treated glass slides and stored overnight at room temperature.
Sections were subsequently immersed in hematoxylin solution
for 10min, followed by removal of excess stain by rinsing in
deionized water, and application of 0.1% acid alcohol for 1 s.
Slides were again washed with deionized water before immersion
in 1% eosin for 5min. Slides were subjected to a final wash with
water before dehydration, mounting in DPX, and microscopic
examination.
ESEM Imaging of Skin Sections
Excised wounds or undamaged skin were directly viewed
under the microscope without any fixation or staining.
Images were acquired using a Zeiss-Evo LS15 environmental
scanning electronmicroscope (ESEM) (Carl Zeiss Ltd.) operating
in extended pressure (EP) mode, and using the following
parameters and conditions: 100µm upper EP aperture, 500µm
lower EDS EP aperture, a chamber pressure of 560–600 pa with c.
85% humidity, an accelerating voltage of 20 kV EHT and using a
five quadrant backscatter detector.
Enumeration of Bacteria and Phage in
Wound Models
To enumerate bacterial cells and phage particles in wound
models, skin explants were immersed in centrifuge tubes
containing 1mL sterilized PBS supplemented with 0.05% Tween-
80 and sonicated for 5min at 60Hz in an ultrasonic bath to
ensure complete dispersal of cells. Subsequently, tubes were
vortexed for 10 s before skin explants were removed, and
cells pelleted by centrifugation for 5min at 8,000 × g. For
enumeration of phage particles, the resulting supernatant was
removed and subject to serial dilution and used to enumerate
phage titers using agar overlays seeded with host strains (as
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FIGURE 3 | Activation of infection responsive dressings. Examples of
non-activated (OFF) and activated (ON) prototype infection responsive
dressings originally described by Thet et al. (2015). Dressings consist of
carboxyfluorescein loaded lipid vesicles embedded in an agarose matrix. At
high concentrations in vesicles, carboxyfluorescein exhibits self-quenching
properties that suppresses visible color. Lysis of vesicles by bacteria liberates
the dye which diffuses through the dressing leading to development of a bright
green color visible to the naked eye. In examples above, dressings incubated
for 6 h in wound models with PBS or S. aureus RN6911 (which is deficient in
the Accessory Gene Regulator agr), show no dressing activation. In contrast,
dressings incubated with MRSA252 and RN6390B (parental strain of RN6911
with functional agr) show clear dressing activation.
described for phage isolation). For bacterial enumeration, the
bacterial pellet was resuspended in 1mL PBS and serial dilutions
performed before plating on agar plates supplemented with
rifampicin (100µg/mL).
XTT Assay
Viable bacterial cells in wound biofilms were measured
using an XTT [2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-
Tetrazolium-5-Carboxanilid] assay. The surfaces of excised
skin sections were washed twice with PBS to remove non-
adherent bacterial cells and placed in a 96-well microtiter plate.
Freshly prepared solutions of 1 mg/mL XTT in sterile PBS
and 0.4mM menadione in acetone were combined at a ratio
of 20:1 (v/v) XTT:menadione, and protected from light until
required. Explants were then immersed in 158 µL PBS and 42
µL XTT:menadione solution, plates wrapped in foil to protect
from light exposure, and incubated for 3 h at 37◦C. Following
incubation, explants were removed fromwells and discarded, and
the colorimetric changes in the remaining solution measured at
490 nm.
Confocal Laser Scanning Microscopy
Excised wounds were inoculated with S. aureus MRSA252-
RifR and incubated for 24 h as described above for evaluation
of bacterial biofilm formation and impact of phage therapy.
Excised wounds were then washed twice by immersion and
gentle shaking in 1mL PBS to remove non-adherent cells
before staining with 2µg/mL DAPI solution and 5µg/mL of
Wheat Germ Agglutinin conjugated to Alexa Flour 488 (WGA-
488; Invitrogen). WGA-488 binds to Poly-N-acetylglucosamine
residues present in the S. aureus biofilm exopolysaccaride
matrix which permits more specific quantification of biofilm
formation (Burton et al., 2007; Skogman et al., 2012). The
surface of the skin explants was immersed in the staining
solution and incubated at room temperature for 20min in
the dark. Following staining, skin explants were washed twice
in 1ml PBS and fixed with 4% paraformaldehyde for 30min
at room temperature in the dark. Skin explants were finally
rinsed with 1ml PBS three times. Images were acquired using
a Leica TCS SP5 confocal laser scanning microscope system
using a 20 × magnification objective. Intensity of fluorescence
signals specific to DAPI and WGA-448 were analyzed using
Fiji-ImageJ software. Images at 1,024 × 1,024 resolution and
signal intensity data were acquired from three randomly selected
regions of each skin sample, with three distinct biological
replicates analyzed.
Measurement of Virulence Gene
Expression in Wound Models
Basal toxin gene expression and toxin gene expression in
wound infections were evaluated using Quantitative real-
time reverse transcription polymerase chain reaction (qRT-
PCR) of agrRNAIII toxin gene (Laabei et al., 2014) in S.
aureus PBS-suspension cells (before inoculation), and cells
recovered from the 6-h porcine skin wound model, respectively.
The PBS-suspended cells were supplemented with 500 µL
RNAlater stabilization solution; dressings were removed from
the wells, and 500 µL RNAlater was added to each well,
and well content mixed, transferred to sterile microcentrifuge
tubes, mixed by vortex for 3min and sonicated at 60Hz for
5min. The porcine skin tissue was then removed and the
RNAlater-suspended cells were kept at −80◦C waiting for RNA
extraction.
Total bacterial RNA was extracted and purified using
the MoBio PowerMicrobiomeTM RNA kit, and the MoBio
DNase MaxTM kit (Cambio Ltd., Cambridge, UK), respectively,
according to manufacturer’s instructions. The treated RNA
was used to generate cDNA using the Qiagen QuantiTect
Reverse Transcription kit (Qiagen,Manchester, UK) according to
manufacturer’s instructions. The RT-qPCR was performed on the
Rotor gene Q thermocycler using the Rotor-Gene SYBR Green
PCR Kit (Qiagen) according to manufacturer’s instructions. The
gene of interest (GOI) agrRNAIII was amplified using previously
published primers (Ferreira et al., 2013), RNAIII-F: 5′-AATTTG
TTCACTGTGTCGATAAT-3′ and RNAIII-R: 5′-TGGAAAATA
GTTGATGAGTTGTT-3′. The S. aureus housekeeping (HKP)
gene DNA gyrase subunit B (gyrB) was amplified using primers
gyrB-F: 5′-GGTGGCGACTTTGATCTAGC-3′, and gyrB-R:5′-
TTATACAACGGTGGCTGTGC-3′ by Labandeira-Rey et al.
(2007).
The PCR reactions were performed in a total volume of 25µL,
which contained 1x Rotor-Gene SYBR Green PCR Master Mix,
5 pmol each of forward and reverse primer, and 150 ng cDNA.
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For no template negative controls (NTC) cDNA was omitted.
PCR products containing GOI and HKP genes were cloned
into the pGEM-T Easy plasmid vectors, and were subsequently
used to create a 5-point 10-fold serial RT-qPCR standard curve
in order to establish efficiencies of RT-qPCR reactions. The
standards also served as PCR calibration samples. Reactions were
carried out using the following conditions: Polymerase activation
at 95◦C for 5min, followed by 40 cycles of two-step cycling,
denaturation at 95◦C for 5 s and a combined annealing and
extension at 60◦C for 10 s. Fluorescence was acquired at the
end of each combined annealing and extension steps. For each
sample three independent biological replicates were assessed,
each with two technical replicates per PCR run. Efficiency (E)
and Ct (threshold cycle) values of RT-qPCRs were calculated
using Qiagen RotorGene software. Expression of agrRNAIII was
normalized to the expression levels of gyrB using the modified
delta-delta Ct method to include the assay efficiency for each
gene, as described by Pfaﬄ (2001), and according to the formula
below:
Normalized relative quantity
=
(EGOI)1Ct GOI (calibrator−Sample)
(EHKP)1Ct HKP(calibrator−Sample)
where GOI, agrRNAIII and HKP, gyrB.
Statistical Analyses
All statistical analysis was performed using Prism 6.0c For Mac
OS X (GraphPad Software Inc., USA). Data was analyzed using
either Student’s t-test, Mann Whitney Test (for non-parametric
data), or the Kruskal-Wallis test with Dunn’s correction for
multiple comparisons with.
RESULTS
Confirmation of Burn-Like Thermal Injury
on ex-Vivo Porcine Skin
Central to the standardization and operation of the ex-vivo
wound model is a bespoke device designed to permit generation
of an array of 24 uniform burn wounds on sections of porcine
skin (Figures 1, 2). To confirm that the Burn Wound Array
Device (BWAD) was able to generate thermal injuries akin
to common burn injuries, and in line with our previous
low-throughput ex-vivo model (Thet et al., 2015), sections of
undamaged skin were compared to BWAD treated skin by
Environmental Scanning Electron Microscopy and histological
analyses (Figure 4). Histopathology showed disruption of the
stratum corneum and damage to the underlying epidermis in skin
heated with the BWAD, consistent with a partial thickness second
degree burn wound (Figure 4A). Areas of skin in contact with the
BWAD also showed distinct differences by ESEM, with “burned”
regions appearing to exhibit damage and fistulae not observed on
skin unexposed to the BWAD (Figure 4B).
Effects of Phage Treatment on Simulated
S. aureusWound Infection
To demonstrate how the ex-vivo model may be used to evaluate
interventions for wound infection, we next used this system to
explore the capacity for S. aureus to grow within wounds created
by the BWAD, and the potential for bacteriophage to control
these infections. The model was operated as outlined in Figure 2
using an antibiotic resistant clinical isolate of S. aureus rendered
resistant to rifampicin (referred to as MRSA252-RifR). This
allowed us to distinguish inoculated cells from any background
skin flora and permitted selective recovery and enumeration.
MRSA252-RifR was confirmed to be susceptible to the previously
isolated S. aureus phage DRA88 (Alves et al., 2014), and phage
SAB4328-A isolated in this study. TEM characterization of these
phage were congruent with previous descriptions of DRA88 as a
Myoviridae (Alves et al., 2014; Figure 5), and showed the newly
isolated SAB4328-A to be a member of the Siphoviridae family
(Figure 5).
To determine the growth of S. aureus within the wound,
and the impact of phage treatment on these simulated wound
infections, numbers of viable RifR cells were enumerated, and
levels of bacterial metabolic activity in wounds measured by
the XTT assay. The application of a single dose of phage
at 4 h post-inoculation (1:1 of each phage) was shown to
result in a significant reduction in numbers of RifR cells and
overall metabolic activity compared with untreated controls, after
models had run for 24 h (Figure 6A). Enumeration of phage
present in these wounds after 24 h also showed higher numbers
were present in the wound than originally inoculated (17.25-fold
increase) indicating phage replication. In wounds subject to a
second phage treatment 24 h after wound inoculation (and run
for a total of 48 h), phage treatment did not result in a significant
drop in numbers of RifR cells as measured by viable cell counts
(Figure 6B), but overall metabolic activity remained significantly
reduced in phage treated wounds (Figure 6B). The number of
phage recovered from 48 h models was also considerably higher
than the cumulative titer of phage applied to these models at the
4 h and 24 h time points (64.64-fold increase), as well as the titer
of phage recovered at the end of 24 hmodels (41.10-fold higher at
48 h vs. 24 h), indicating phage continued to replicate in models
run for longer periods of time.
Visualization of Biofilm Formation in
Wound Models and Impact of Phage
Treatment
To confirm S. aureus MRSA252-RifR forms biofilms in our
ex-vivo wound model, and understand if phage treatment
influenced the formation of these communities, we directly
visualized MRSA252-RifR infected wounds using Confocal Laser
Scanning Microscopy. To specifically assess biofilm formation,
wounds were stained with the general DNA stain DAPI, and
the fluorescent-lectin conjugate WGA-488, which binds to
poly-N-acetylglucosamine residues present in the exopolymeric
matrix of Staphyloccocus sp. biofilms. Imaging of wounds 24 h
after MRSA252-RifR inoculation clearly showed biofilms formed
within wounds, compared to un-infected controls (Figure 7).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 June 2018 | Volume 8 | Article 196
Alves et al. A High-Throughput ex-Vivo Burn Wound Model
FIGURE 4 | Evaluation of simulated burn wounds. To confirm that the BWAD was able to generate representative thermal injuries in ex-vivo porcine skin sections,
areas of skin in contact with the BWAD after heating to 100◦C were examined by histology and directly by environmental scanning electron microscopy (ESEM), and
compared to uninjured skin. (A) Thin sections of undamaged and burned skin subjected to H&E staining and histological analysis (x100 magnification). The stratum
corneum (SC), Epidermis (E), and dermis (D) are clearly visible and discernible on the undamaged skin sections. In contrast, these structures are disrupted in skin
section from BWAD exposed skin, consistent with partial thickness burn injuries. (B) ESEM of the surface of undamaged porcine skin and areas in contact with the
BWAD. Scale bar = 20µm.
FIGURE 5 | Morphology of bacteriophage used in wound models. The previously isolated phage DRA88 (Alves et al., 2014), and the newly isolated phage
SAB4328-A were examined by transmission electron microscopy. Characteristics of the DRA88 virion were congruent with membership of the Myoviridae family as
previously described, while characteristics of SAB4328-A were in keeping with membership of the Sipohoviridae family. Scale bar represents 100 nm.
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FIGURE 6 | Impact of bacteriophage treatment on simulated wound infection. The potential for bacteriophage to control the growth of bacteria in burn wounds was
evaluated using the ex-vivo porcine skin model as outlined in Figure 2. The effects of phage treatment were assessed by recovery and enumeration of viable cells, as
well as estimates of cellular metabolic activity as measured by the XTT assay, in phage treated vs. untreated wounds inoculated with the multidrug resistant S. aureus
MRSA252. (A) Evaluation of a single phage treatment. Wounds were treated with a single dose of phage 4 h after inoculation and levels of viable bacterial cells
assessed after a total of 24 h incubation. (B) Evaluation of two phage treatments. Wounds were treated with an initial dose of phage 4 h after inoculation, and again
after 24 h of incubation. Levels of viable bacterial cells were assessed after a total of 48 h incubation. Data shows the mean of at least three independent replicates,
and error bars show standard error of the mean. Statistically significant differences are denoted by: *P ≤ 0.05, ****P < 0.0001.
Moreover, a clear reduction in the level of MRSA252-RifR
biofilm was evident in wounds treated with phage 4 h post
inoculation, and also imaged after 24 h incubation (Figure 7).
To support the subjective assessment of confocal images,
the intensity of fluorescent signals specific to DAPI staining
or WGA-488 biofilm staining, were also measured. This
demonstrated a statistically significant reduction in both DAPI
and the biofilm-related WGA-488 fluorescent signal in phage
treated wounds, compared to infected but untreated wounds
(Figure 7).
Evaluation of Accessory Gene Regulator
(agr) Activity and Activation of
Infection-Responsive Wound Dressing
To evaluate the population density-dependant regulation of
virulence gene expression during S. aureus growth in wound
models, and demonstrate the compatibility of our model with
molecular genetic assays, we used qRT-PCR to measure the
activity of the accessory gene regulator (agr) in 28 strains
of S. aureus. The agr system coordinates the population
density-dependant expression of a range of virulence genes
including toxins (Recsei et al., 1986; Novick, 2003; Laabei
et al., 2014). In parallel we tested the ability of each strain to
activate prototype infection-responsive dressings, which contain
carboxyfluorescein loaded lipid vesicles that are lysed though
the action of S. aureus toxins regulated by the agr (Laabei
et al., 2014; Thet et al., 2015; Figure 3). Vesicle lysis and
dye release leads to a color change visible to the naked eye
that can be used to signal clinically relevant infection (Thet
et al., 2015). Evaluation of agr activity in cultures used to
inoculate wounds at the beginning of experiments (T0) and
also after 6 h growth in wound models (T6), revealed much
strain-to-strain variation in agr activity with some strains
exhibiting a reduction in agr activity during growth in models
(Figure 8A). However, for most strains agr activity increased
during growth of bacteria in wound models (Figure 8A),
and across all strains mean agr activity was significantly
greater at the end of experiments (Figure 8B). Strains capable
of activating prototype dressings also showed a significantly
greater mean level of agr activity at the end of experiments
(T6), compared to strains that did not activate dressings
(Figures 8A,C).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 June 2018 | Volume 8 | Article 196
Alves et al. A High-Throughput ex-Vivo Burn Wound Model
FIGURE 7 | Visualization of biofilm formation in wound models and impact of phage therapy. To confirm biofilm formation in the ex-vivo wound model and assess the
impact of phage treatment, excised wounds were stained with the general DNA stain DAPI, and WGA-488 fluorescent-lectin conjugate (Wheat Germ Agglutinin with
Alexa Flour 488) which binds to poly-N-acetlyglucosamine residues in S. aureus biofilm matrix. (A) Visualization of infected and uninfected wounds by confocal laser
scanning microscopy. DAPI staining appears as blue, while WGA-488 staining appears as green areas which are indicative of S. aureus biofilm formation. Control,
untreated skin PBS only; +MRSA252, wounds inoculated with S. aureus MRSA252-RifR only; +MRSA252+phage, wounds inoculated with S. aureus MRSA252-RifR
and subject to phage treatment 4 h post inoculation. (B,C) The intensity of fluorescence signal from DAPI or WGA-488 staining measured during CLSM imaging of
skin sections. Charts show mean values from three randomly selected regions of skin, in each of three independent replicates. Error bars show standard error of the
mean. Statistically significant differences in fluorescence intensity are given by: ****P < 0.0001 vs. Control; ####P < 0.0001 vs. MRSA252 only. All images and
measurements were taken after 24 h incubation.
DISCUSSION
The study of burn wound infection and biofilm formation has
benefitted immensely from the development and application
of a wide range of both in-vivo and in-vitro model systems
(Sun et al., 2008; Dai et al., 2011; Guggenheim et al., 2011;
Lebeaux et al., 2013; Roy et al., 2014; Ganesh et al., 2015;
Seaton et al., 2015). Collectively the application of these models
has considerably advanced our understanding of pathogenesis
and biofilm formation in wound infection, but each model has
particular merits and limitations, and choice of model is typically
a compromise between affordability, ethical considerations, and
the aims of a study. There remains considerable scope to improve
the range of available models to better facilitate different aspects
of wound biofilm study. This includes the development of
additional in-vitro or ex-vivo models with a greater capacity to
support the progression of work from early stage discovery of
new antimicrobial agents or fundamental processes in biofilm
formation, to more complex investigations of host-microbe
interactions and wound healing using in-vivomodels.
Here, we describe the operation of an ex-vivo porcine skin
model designed to support laboratory study of biofilm formation
in burn wounds, and facilitate high throughput screening
applications. The core of this model is the burn wound array
device (BWAD), used in conjunction with ex-vivo porcine
skin sections as a substrate for bacterial growth and biofilm
formation. The BWAD was shown to generate thermal damage
to skin sections similar to partial thickness burns, and both
histological analyses and ESEM imaging confirmed damage to
the epidermis and underlying collagen consistent with such
injuries. The BWAD also ensures consistency between wounds
within the array, and those generated on different skin sections,
by allowing factors such as temperature, pressure, and time
used to generate thermal damage to be easily controlled and
standardized during model operation. There is also considerable
scope to vary these parameters to tailor models according
to individual requirements. The wounds generated were also
shown to be capable of supporting bacterial growth and biofilm
formation without addition of further exogenous media, and
the model is compatible with a range of common analytical
techniques for monitoring bacterial growth, metabolic activity,
biofilm formation, and gene expression. These included specific
staining and visualization of biofilms using confocal laser
scanning microscopy, and excellent reproducibility was observed
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FIGURE 8 | Evaluation of agr activity and activation of infection-responsive dressing materials. To understand how S. aureus virulence gene regulation was influenced
by growth in the porcine wound model, and relate this to activation of prototype infection responsive dressings, the activity of the Accessory Gene Regulator (agr) was
measured in 28 strains (Table 1). Agr activity was assessed by qRT-PCR of RNAIII relative to the housekeeping gene gyrB. (A) Heatmap showing RNAIII:gyrB relative
gene expression in each strain between time points assessed: Initial inoculum (T0) and after 6 h in growth in wound models (T6). Shading of cells indicates
fold-difference in RNAIII:gyrB expression as indicated by the associated scale. Strains in bold denote those not activating the prototype dressing during the assay. (B)
Shows mean RNAIII:gyrB relative expression in all strains, in initial inoculum (T0) and after 6 h growth in wound models (T6). (C) Shows mean RNAIII:gyrB relative
expression after 6 h growth in models for strains activating prototype infection-responsive dressings (ON), compared to strains that did not elicit a color change in
dressings (OFF). Examples of activated and non-activated dressings are provided in Figure 3. All values show the means of three replicate experiments. Error bars
show standard error of the mean. **P ≤ 0.02, ****P < 0.0001.
between biological replicates in all assays employed in this
study.
Collectively these features provide a high-throughput model
with good reproducibility for the study of burn wound infection
and biofilm formation, which should also provide an improved
representation of the wound environment, compared to models
using abiotic surfaces or mammalian cell monolayers. It is also
notable how other in-vitro wound models have been used in
conjunction with in-vivo studies to improve performance and
study design. In particular, several studies have described the
use of in-vitro systems to prepare biofilms for transplantation
into in-vivo wound models (Sun et al., 2008; Dalton et al., 2011;
Guggenheim et al., 2011). In this context it seems logical that
biofilms preformed on ex-vivo skin sections, rather than plastic
substrates, could be more compatible with in-vivo applications.
Nevertheless, as an ex-vivo model, notable limitations will be
inherent in the system we describe here, restricting types of study
for which this is a suitable model (Sun et al., 2008; Guggenheim
et al., 2011; Lebeaux et al., 2013; Ganesh et al., 2015). In the
case of the preliminary proof-of-concept studies we present in
this manuscript, only single species biofilms of S. aureus were
evaluated (discussed in detail below). However, this aspect of the
work described does not necessarily reflect a deficiency in the
model per se, and previous studies using our more basic porcine
skin model showed that growth of numerous clinically relevant
species are supported (Thet et al., 2015), highlighting the capacity
to develop protocols for growth of polymicrobial biofilms in this
model.
In contrast, a lack of host response and the relatively short
duration (up to 4 days) over which experiments with our ex-vivo
model may be conducted, are clearly key limitations also found
in in-vitro models (Lebeaux et al., 2013; Roy et al., 2014; Ganesh
et al., 2015). These features significantly reduce the utility of
our ex-vivo system to study fundamental aspects of the interplay
between biofilm formation and wound healing, in terms of host
response and wound repair processes, as well as chronic long-
term wound infections (Roy et al., 2014; Ganesh et al., 2015).
As an example, Roy et al. (2014) have recently described the use
of an in-vivo porcine model of chronic burn wound infection
to study host response to biofilm formation (Roy et al., 2014).
Using this model the presence of biofilm-induced microRNAs in
skin at the wound periphery were identified, which silenced genes
involved in tight junction formation, and presumably influence
wound closure (Roy et al., 2014). In this case, the use of an in-vivo
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porcine model is clearly required to model long-term chronic
infections with biofilm formation over a period of weeks, and
also evaluate impact on host wound healing processes including
immune response and gene expression.
However, while in-vivo studies like those described by
Roy et al. (2014) are clearly indispensable for fundamental
investigations of wound healing and host response to infection,
they are less well-suited to the early stage discovery and
evaluation of novel anti-microbial agents for control of wound
infection. Conversely, because our ex-vivo model is relatively
high throughput, low cost, and does not use live animals, it is
well-suited to the early stage study and evaluation of approaches
to control bacterial growth or biofilm formation, before more
complex and ethically contentious experiments are considered
(Sun et al., 2008; Guggenheim et al., 2011; Lebeaux et al.,
2013; Ganesh et al., 2015). This not only includes screening of
compound libraries, and the evaluation of susceptibility across
many isolates (in terms of minimum bactericidal concentration
or minimum biofilm eradicating concentration), but also the
initial evaluation of novel and untested approaches to combat
biofilm formation. The use of animal models for these initial
studies is difficult to justify from both ethical and financial
perspectives, without reference to initial data supporting the
potential to control biofilm formation or microbial growth.
Moreover, skin sections used in our model may be derived from
considerably fewer animals than typically required for in-vivo
experiments, and from those killed for other purposes (as was
the case for this work), including reasons unrelated to scientific
research.
To demonstrate the potential utility of this model for early
stage development of novel infection control strategies, we
evaluated the ability of bacteriophage (or phage) to inhibit
biofilm formation by S. aureus. Phage are bacterial viruses that
specifically infect and kill bacteria, and represent a promising
alternative to antibiotics, particularly for infections involving
bacterial biofilms (Curtin and Donlan, 2006; Lu and Collins,
2007; Carson et al., 2010; Fu et al., 2010; Alves et al., 2014,
2016; Lehman and Donlan, 2015; Nzakizwanayo et al., 2016).
Of particular relevance in this context are strategies phage
have evolved in order to disrupt bacterial biofilms to access
bacterial hosts growing in these communities (Hughes et al.,
1998; Sutherland et al., 2004; Donlan, 2009; Harper et al., 2014),
and a number of recent studies have begun to highlight the
potential for phage to be used to control wound infection (Busch
et al., 2000; Marza et al., 2006; McVay et al., 2007; Kumari et al.,
2009a,b; Rose et al., 2014).
Data generated in this study using our ex-vivo model showed
that a single phage treatment was able to reduce S. aureus biofilm
formation when assessed at the 24 h timepoint. More detailed
examination by selective staining and confocal microscopy
supported the formation of biofilms in wounds, and a significant
reduction in biofilm formation at the 24 h time point after a
single dose of phage. However, it was notable that in models
run for 48 h and subject to successive doses of phage, viable cell
counts were not significantly reduced compared to untreated
controls. This was despite a significant reduction in metabolic
activity in XTT assays, and clear evidence that phage continued
to proliferate in wounds over this period. This discrepancy may
relate to the different ways in which each method (viable cell
counts and the XTT assay) assesses the bacterial population. It is
likely that the reduced metabolic activity observed at 48 h is not
fully related to reduced numbers of viable cells, but an indication
of prevailing environmental parameters in these longer running
experiments. In particular, cells located deeper within mature
and more established biofilms are known to enter a quiescent
state with low metabolic activity, distinct from planktonic cells
or those at earlier stages of biofilm formation, or at the biofilm
periphery (Donlan and Costerton, 2002; Zhao et al., 2013). There
is also potential for development and selection of phage resistant
cells over this time period, which could contribute the differences
in viable cell counts and XTT assays at these later time points.
Although phage are clearly still able to proliferate over the
course of longer 48 h experiments, collectively our data suggests
that this replication, and additional phage doses, is not sufficient
to further reduce the bacterial population. This likely indicates
that host-phage interactions may have reached an equilibrium,
and may also reflect a reduced susceptibility of more mature
biofilms to phage infection. Collectively, these data may indicate
that phage are more effective if applied early in infection or
prophylactically, in order to inhibit biofilm formation, but less
effective if biofilms have already developed in the wound. Similar
findings have also been noted for studies of phage therapy in
other biofilm related infections (Nzakizwanayo et al., 2016).
Alternatively, it should be noted that although the combined use
of multiple phage as a cocktail would seem a logical approach
to enhance activity and offset the development of resistance, in
reality there remains the potential for antagonistic interactions
between individual phage which could reduce efficacy of the
cocktail in controlling the bacterial population. Nevertheless,
these initial investigations provide good preliminary insights
in the use of phage to control biofilms in this setting, and
demonstrate how this ex-vivo system may be used in early stage
investigations to select promising phage, or phage combinations
for further evaluation in more complex in-vivomodels.
Our model also provides a useful and accessible platform
for studies seeking to understand basic features and molecular
genetic aspects of biofilm formation, with the view to identifying
new targets for control or detection of biofilm formation,
or to better understand this process in bacteria. This could
include approaches such as the large-scale screening of mutant
libraries to identify those defective in traits of interest (where
use of animals is generally not feasible or justifiable); or
the more detailed phenotypic characterization of mutants
recovered from competitive in-vivo screening of mutant
pools representing genome wide saturating mutagenesis
of target pathogens, such as Tn-seq based investigations
(Lebeaux et al., 2013; Zhao et al., 2013). Here, we used
our model to monitor bacterial gene expression during
biofilm formation, demonstrating its compatibility with
challenging molecular biology techniques such as recovery of
RNA.
This work showed that in S. aureus population density-
dependant expression of virulence attributes is evident in our
model, as indicated by agr activity, and activation of prototype
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infection-responsive dressings which rely on agr mediated toxin
production (Laabei et al., 2014; Thet et al., 2015). The results
obtained in this study are congruent with our previous studies
of vesicle lysis by S. aureus with regard to toxin production
and agr activity. For the most part, strains we evaluated
in earlier studies, and also in the current work, produced
comparable results. Strains RN6911, MRSA71, MRSA378, and
MRSA707 failed to activate dressings while MRSA69, MRSA252,
and RN6390B elicited a clear color change both in our
models and previous studies of vesicle lysis in broth cultures
(Laabei et al., 2014). In addition, the overall differences in agr
activity in these strains was also in line with our previous
work (Laabei et al., 2014), in that strains failing to activate
dressings or lyse vesicles exhibited little or no notable agr
activity. This general pattern was also evident in the wider
panel of strains tested in this study with respect to dressing
activation.
Notable exceptions, however, were strainsMRSA10, MRSA56,
and MRSA378, which exhibited an increase in agr activity
during growth in wound models comparable to the majority
of other strains capable of activating dressings, but failed to
activate dressings during the 6 h test period. For MRSA378
the lack of dressing activation and the general lack of agr
activity measured in broth cultures at the start of experiments
was in keeping with observations we reported previously in
broth cultures (Laabei et al., 2014). This was contrasted by the
increased agr activation in this strain at the end of the wound
model experiments, which was not consistent with our previous
data. These observations suggest that features of the wound
model not replicated in abiotic assays (such as broth cultures)
support increased agr activity in some strains. Discrepancies
between agr activity and dressing activation in these strains may
therefore be the result of mutations in other genes, aspects of
toxin translation and export, or arise from differences in the
rate or specific timing at which agr expression increases and
the total level of toxins generated during these assays. This
may also include the relative fitness of different strains and
in the wound model and ability to gown to levels sufficient
to trigger agr activation, which should be explored in further
studies.
Collectively these observations suggest our wound model
can provide insights into the regulation of processes such as
virulence factor production and biofilm formation not obtained
in in-vitro models. This is also supported by previous studies in
our initial low-throughput ex-vivo model, which indicated that
for some species, clinically relevant phenotypes not observed in
in-vitro systems were apparent in the ex-vivo model (Thet et al.,
2015). This likely stems from the use of porcine skin tissue as
a primary substrate for growth and biofilm formation, which
is a major difference to other popular in-vitro wound models
which utilize abiotic substrates (Sun et al., 2008; Guggenheim
et al., 2011), and further highlights the benefits of using
an ex-vivo system for this type of study. This should also
provide more robust data on which to select agents for further
study, inform the design of subsequent in-vivo studies, and
better support basic molecular genetic studies of the infection
process, which will in turn contribute to the more effective
use of animals in research and the reduction of numbers
used.
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